Back
Capricor Therapeutics Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Buy
54
CAPR
Capricor Therapeutics
Last Price:
5.36
Seasonality Move:
7.95%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing selling pressure, which indicates risk of future bearish movement.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.38 | Buy |
| 20-day SMA: | 5.46 | Buy |
| 50-day SMA: | 5.8 | Sell |
| 200-day SMA: | 4.74 | Buy |
| 8-day EMA: | 5.39 | Buy |
| 20-day EMA: | 5.51 | Sell |
| 50-day EMA: | 5.5 | Sell |
| 200-day EMA: | 4.85 | Buy |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 47.2 | Sell |
| Chaikin Money Flow: | -223570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.08 - 6.32) | Sell |
| Bollinger Bands (100): | (4.06 - 6.06) | Buy |
Capricor Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 5.46 while CAPR 8-day simple moving average is 5.38, which is a Buy signal.
- The stock price of CAPR is 5.46 while Capricor Therapeutics 20-day SMA is 5.46, which makes it a Buy.
- Capricor Therapeutics 50-day simple moving average is 5.80 while CAPR share price is 5.46, making it a Sell technically.
- CAPR stock price is 5.46 and Capricor Therapeutics 200-day simple moving average is 4.74, creating a Buy signal.
CAPR Technical Analysis vs Fundamental Analysis
Buy
54
Capricor Therapeutics (CAPR)
is a Buy
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a Buy
The current Capricor Therapeutics [CAPR] share price is $5.46. The Score for CAPR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
172.01M
Price in USD:
5.46
Share Volume:
355.08K
Capricor Therapeutics 52-Week Range
52-Week High:
8.22
52-Week Low:
2.68
Buy
54
Capricor Therapeutics (CAPR)
is a Buy
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?
The Capricor Therapeutics stock price is 5.46 USD today. -
Will CAPR stock go up or go down?
Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Capricor Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is not overvalued.
Is Capricor Therapeutics Stock a Buy?
- Capricor Therapeutics share price is 5.46 while CAPR 8-day exponential moving average is 5.39, which is a Buy signal.
- The stock price of CAPR is 5.46 while Capricor Therapeutics 20-day EMA is 5.51, which makes it a Sell.
- Capricor Therapeutics 50-day exponential moving average is 5.50 while CAPR share price is 5.46, making it a Sell technically.
- CAPR stock price is 5.46 and Capricor Therapeutics 200-day simple moving average is 4.85, creating a Buy signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.53 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
- CAPR Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Capricor Therapeutics is a Sell
- Capricor Therapeutics Relative Strength Index (RSI) is 47.2, which suggest Capricor Therapeutics is oversold
- The Bollinger Bands (25) for Capricor Therapeutics is (5.08 - 6.32), which suggest Capricor Therapeutics is a Buy
- The Bollinger Bands (100) for Capricor Therapeutics is (4.06 - 6.06), which suggest Capricor Therapeutics is a Buy
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.